4 unknown. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 1 | 1 | Unknown 1 |
Follow T Cell Lymphoma: new trials by email Literature Review of T Cell Lymphoma trials Research Report on T Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma Chidamide combined with BEAM - T Cell Lymphoma | Phase 2 | Unknown | Ruijin Hospital | 23 | 2022-05-28 | 2022-09-29 |
| CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma. HSP-CAR30 - Hodgkin Lymphoma, Adult, T Cell Lymphoma | Phase 1 / Phase 2 | Unknown | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 30 | 2020-09-29 | 2020-12-04 |
| Trial of Endostar Combined With CHOPT for T Cell Lymphoma Endostar and CHOPT - T Cell Lymphoma | Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 30 | 2011-06-01 | 2015-11-04 |
| Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma endostar and CHOP - T Cell Lymphoma | Phase 2 | Unknown | Fudan University | 15 | 2009-08-01 | 2010-09-15 |
Lymphoma, T-Cell (4) · Hodgkin Disease (1) · Lymphoma, T-Cell, Peripheral (1)
Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoma (4) · Lymphoma, Non-Hodgkin (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4)
endostar protein (2) · Endostatins (1)
Fudan University (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Ruijin Hospital (1) · Tianjin Medical University Cancer Institute and Hospital (1)
China (3) · Spain (1)
Junning Cao, MD (1)